Home・Akcijų sąrašas・Humana Inc

Humana Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

386.84 0.59

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

380

Max

389.39

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-491M 693M
Pardavimai	1.2B 41B
P/E Sektoriaus vid.	36.353 57.002
Pelnas, tenkantis vienai akcijai	7.61
Dividendų pajamingumas	0.92
Pelno marža	1.696
Darbuotojai	67,060
EBITDA	-658M 1.3B

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+10.49% upside

Dividendai
By Acuity
Dividendų pajamingumas Sektoriaus vid.	0.92% 2.22%
Kitas uždarbis	2026-11-04
Kitas dividendų mokėjimo data	2026-10-30
Kita Ex Dividend data	2026-09-25

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-427M 46B
Ankstesnė atidarymo kaina	386.25
Ankstesnė uždarymo kaina	386.84

Naujienos nuotaikos

By Acuity

17%

83%

43 / 340 reitingas Healthcare

Humana Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-14 19:46; UTC

Humana Inc shares are higher today, reflecting a broader positive market trend despite recent negative sentiment following a decline in U.S. retail sales.

2026-08-12 20:01; UTC

Humana Inc shares are higher during Wednesday's session, continuing an upward trend since Tuesday. The move occurs amid mixed macroeconomic signals and geopolitical tensions.

2026-08-10 19:16; UTC

News

Humana shares advance as JPMorgan raises price target to $393.

2026-08-07 20:03; UTC

Humana Inc shares are higher today, continuing strong momentum from recent sessions. No specific company news was identified to explain this price action.

2026-08-06 23:02; UTC

Humana Inc shares are lower in after-market trading, continuing a decline since Thursday's close and remaining below their 20-day moving average.

2026-08-05 19:56; UTC

News

Social Media

Morgan Stanley upgraded Humana Inc to Equal-Weight and raised its price target to $370. Shares are gaining amid positive analyst sentiment and service area expansion.

2026-08-04 20:04; UTC

News

Humana Inc is under investigation by Bronstein, Gewirtz & Grossman, LLC, raising concerns among investors and contributing to a decline in shares.

2026-08-03 22:26; UTC

Humana Inc. shares are higher in after-market trading, continuing gains since Monday's close, though still below the 20-day moving average.

2026-07-31 19:36; UTC

News

Humana Inc shares are lower today amid broader weakness in the Managed Health Care sector, despite price target increases from TD Cowen and Barclays.

2026-07-30 18:36; UTC

News

Upgrades from Guggenheim, Evercore ISI boost Humana investor sentiment.

2026-07-29 23:06; UTC

Humana Inc shares are trading lower in after-market hours, continuing a decline below the 20-day moving average and near the one-month trading range's lower end.

2026-07-28 23:16; UTC

News

Social Media

Humana shares decline in after-market trading following the end of a Medicare drug subsidy program, which may raise costs for seniors and pressure insurers.

2026-07-27 19:16; UTC

News

Humana Inc. shares are lower as Schubert Jonckheer & Kolbe LLP investigates potential false statements about healthcare costs amid ongoing securities fraud claims.

2026-07-24 19:31; UTC

Humana Inc's shares are lower today amid broader weakness in the Managed Health Care sub-sector, reversing a trend of higher daily closes since Thursday.

2026-07-22 19:26; UTC

Humana Inc. shares are lower today amid notable volatility and a mixed performance in global markets, with U.S. indices generally declining.

2026-07-20 18:46; UTC

Humana Inc's shares are higher today, reflecting a slight increase since Friday's close. The stock is near the upper end of its one-month trading range.

Akcijų palyginimas

Kainos pokytis

Humana Inc Prognozė

Kainos tikslas

By TipRanks

10.49% į viršų

12 mėnesių prognozė

Vidutinis 429.86 USD 10.49%

Aukščiausias 624 USD

Žemiausias 280 USD

Remiantis 23 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Humana Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

23 ratings

Pirkti

Laikyti

Parduoti

Remiantis 23 analitikų, pateikusių Humana Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

43 / 340 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Humana Inc

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.